Physician profile
Christopher Hover
NPI 1275105892
$5,088.81
in general payments reported to CMS, 2019-2025
32 companies · $667 in 2025
The $667 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,650 · 2022: $1,044 · 2023: $656 · 2024: $1,072 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,395.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $1,679.12 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $613.00 | 2022-2025 | Belbuca, Xtampza |
| Scilex Pharmaceuticals INC. | $548.17 | 2021-2025 | Ztlido |
| Valinor Pharma, LLC | $547.05 | 2023-2025 | Movantik |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $351.42 | 2021-2025 | Relistor |
| Boston Scientific Corporation | $277.42 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Tersera Therapeutics LLC | $254.08 | 2022-2025 | Prialt |
| Medtronic, INC. | $135.77 | 2022-2023 | Vanta Adaptivestim |
| Pfizer INC. | $79.78 | 2023-2025 | |
| Impel Pharmaceuticals LLC | $78.08 | 2025 | Trudhesa |
| Vertos Medical, INC. | $69.33 | 2024 | Mild Device Kit |
| Biohaven Pharmaceutical Holding Company Ltd. | $54.18 | 2022 | |
| Ibsa Pharma INC. | $47.70 | 2022 | |
| Fidia Pharma USA INC. | $39.59 | 2022 | |
| Ossur Americas, INC. | $30.90 | 2025 | Unloader One X |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $19.56 | 2023 | Wegovy |
| Si-Bone, INC. | $19.49 | 2024 | |
| Averitas Pharma INC. | $18.75 | 2025 | Qutenza |
| Spr Therapeutics, INC | $18.38 | 2024 | Sprint Pns System |
| Otsuka America Pharmaceutical, INC. | $18.23 | 2025 | Rexulti |
| Almatica Pharma LLC | $17.32 | 2023 | Gralise |
| Teva Pharmaceuticals USA, INC. | $16.53 | 2023 | Austedo Xr |
| Appliedvr INC | $16.43 | 2025 | Relievrx |
| Redhill Biopharma INC. | $16.32 | 2022 | |
| Biodelivery Sciences International, INC. | $16.24 | 2021 | |
| Amgen INC. | $16.16 | 2021 | |
| Spinal Simplicity, LLC | $15.46 | 2025 | Ha Minuteman G3-R |
| International Rehabilitative Sciences, INC | $15.30 | 2024 | Rs 4i Plus Sequential Stimulator |
| Grt US Holding, INC. | $15.23 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.99 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.50 | 2023 | Seglentis |
| Globus Medical, INC. | $14.33 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.